Overview

INVEST: INternational VErapamil SR Trandolapril STudy

Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
Because blood pressure affects the heart, blood vessels, kidneys, and the entire body, it is important to keep it as normal as possible. There are several different ways to control blood pressure and to prevent or limit the development of heart disease due to high blood pressure. The purpose of this study is to compare two treatments to see how well they work and the difference in their side effects. One treatment includes the use of a calcium antagonist drug (Isoptin sustained release [SR] or Verapamil SR). The other treatment excludes the calcium antagonist and may include a non-calcium antagonist drug called a beta blocker (Tenormin or Atenolol). Both treatments may also include medication called angiotensin converting enzyme (ACE) inhibitors and water pills. None of the drugs in this study are experimental, they are all approved by the Food and Drug Administration (FDA).
Phase:
Phase 4
Details
Lead Sponsor:
University of Florida
Collaborator:
Abbott
Treatments:
Atenolol
Hydrochlorothiazide
Trandolapril
Verapamil